Cargando…
Method comparison of SARS-CoV-2 serology assays involving three commercially available platforms and a novel in-house developed enzyme-linked immunosorbent assay
Autores principales: | Seegmiller, Jesse C., Kokaisel, Emily L., Story, Steven J., Zaun, Christopher P., Peters, Jennifer M., Thomas, Stefani N., Karger, Amy B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc. on behalf of The Canadian Society of Clinical Chemists.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417259/ https://www.ncbi.nlm.nih.gov/pubmed/32791053 http://dx.doi.org/10.1016/j.clinbiochem.2020.08.004 |
Ejemplares similares
-
Performance of commercially available anti-HDV enzyme-linked immunosorbent assays in Taiwan
por: Lin, Guan-Yu, et al.
Publicado: (2020) -
Enzyme-Linked Immunosorbent Assay and Serologic Responses to Pneumocystis jiroveci
por: Daly, Kieran R., et al.
Publicado: (2004) -
Diagnostic Performance of Commercially Available Enzyme-Linked Immunosorbent Assay Kit in the Diagnosis of Extrapulmonary Tuberculosis
por: Sankar, Manimuthu Mani, et al.
Publicado: (2013) -
Multi-laboratory comparison of three commercially available Zika IgM enzyme-linked immunosorbent assays
por: Basile, Alison Jane, et al.
Publicado: (2018) -
Validation of an Indirect Immunofluorescence Assay and Commercial Q Fever Enzyme-Linked Immunosorbent Assay for Use in Macropods
por: Tolpinrud, Anita, et al.
Publicado: (2022)